Public Comment Now Open - ASAM Clinical Considerations for Engagement and Retention of Non-Abstinent Patients in Substance Use Treatment
The 探花合集 (ASAM) has made available for public comment a draft of its Clinical Considerations for Engagement and Retention of Non-Abstinent Patients in Substance Use Treatment. The deadline to submit comments is June 3, 2024. Please see below for more information and instructions.
Overview
Inititation, engagement, and retention in treatment are critical factors that impact long-term outcomes for substance use disorders (SUDs); early treatment engagement and longer durations of treatment predict better clinical outcomes. Despite this, patients are regularly dissuaded from initiating treatment until they commit to full sustained abstinence from all intoxicants, and too frequently are administratively discharged from SUD treatment programs during instances of substance use recurrence. This clinical considerations document was developed to support SUD treatment programs providers to increase treatment engagement and retention while addressing the complexities associated with patient non-abstinence.
This project is funded by the California Department of Health Care Services.
Instructions for Review
Comments will be collected through a survey to facilitate reconciliation of feedback. A preview of the survey can be found . When providing your comments, please include the page and line number (not a range, just a single number) in the appropriate boxes. If your comment refers to a range of line numbers, you only need to indicate the first line number within the range. To make a general comment about the document as a whole, put 0 for page and line numbers. You can provide up to 100 comments. If you would like to provide additional comments, you can submit the survey again. Feedback must be submitted through this survey to be considered.
Note: The system does not allow you to save your progress to return later. Always submit your response before exiting. If you have additional comments at a later time, you can reenter the survey and submit a new response.
If you have any questions, please contact Taleen Safarian at . Thank you in advance for your participation in this important initiative. We look forward to your feedback.